{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:31:11Z","timestamp":1786113071448,"version":"build-2736575974"},"reference-count":0,"publisher":"American Association for the Advancement of Science (AAAS)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"DOI":"10.1126\/science.z031k3h","type":"dataset","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:15:23Z","timestamp":1785874523000},"source":"Crossref","is-referenced-by-count":0,"title":["As a weekly anti-HIV pill nears the market, vaccine research faces new hurdles"],"prefix":"10.1126","member":"221","container-title":["AAAS Articles DO Group"],"original-title":[],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:30:40Z","timestamp":1785951040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/content\/article\/weekly-anti-hiv-pill-nears-market-vaccine-research-faces-new-hurdles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1126\/science.z031k3h","relation":{},"subject":[],"published":{"date-parts":[[2026,8,4]]}}}